Arcturus Therapeutics Holdings (ARCT) Accumulated Depreciation & Amortization: 2018-2025
Historic Accumulated Depreciation & Amortization for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Sep 2025 value amounting to $12.0 million.
- Arcturus Therapeutics Holdings' Accumulated Depreciation & Amortization rose 8.91% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.8 million, marking a year-over-year increase of 27.71%. This contributed to the annual value of $11.8 million for FY2024, which is 35.14% up from last year.
- Per Arcturus Therapeutics Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $12.0 million for Q3 2025, which was down 10.60% from $13.4 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Accumulated Depreciation & Amortization high stood at $13.4 million for Q2 2025, and its period low was $3.4 million during Q1 2021.
- Over the past 3 years, Arcturus Therapeutics Holdings' median Accumulated Depreciation & Amortization value was $10.1 million (recorded in 2024), while the average stood at $10.0 million.
- Data for Arcturus Therapeutics Holdings' Accumulated Depreciation & Amortization shows a peak YoY spiked of 51.47% (in 2023) over the last 5 years.
- Over the past 5 years, Arcturus Therapeutics Holdings' Accumulated Depreciation & Amortization (Quarterly) stood at $4.3 million in 2021, then soared by 35.88% to $5.8 million in 2022, then spiked by 51.13% to $8.7 million in 2023, then surged by 35.14% to $11.8 million in 2024, then increased by 8.91% to $12.0 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $12.0 million for Q3 2025, versus $13.4 million for Q2 2025 and $12.6 million for Q1 2025.